Yardley MM et al., 2012-08: The founding preclinical paper for the alcohol hypothesis: ivermectin, a P2X4 receptor modulator, reduced alcohol self-administration and preference across several mouse models in both sexes.
IVM (1.25-10 mg/kg, intraperitoneal) significantly reduced 24-h alcohol consumption and intermittent limited access (4-h) binge drinking, and operant alcohol self-administration (1-h).
Yardley MM et al., 2012-08: The founding preclinical paper for the alcohol hypothesis: ivermectin, a P2X4 receptor modulator, reduced alcohol self-administration and preference across several mouse models in both sexes. Animal study (male and female C57BL/6 mice), multiple alcohol self-administration paradigms, doses 1.25-10 mg/kg; no human subjects; United States. Authors declare no conflict of interest. Mechanism: ivermectin antagonises ethanol-mediated inhibition of P2X4 receptors. Doses 1.25-10 mg/kg intraperitoneal; effect was dose-dependent and tracked peak brain concentrations; ivermectin also reduced saccharin intake but not operant sucrose self-administration, which the authors report as a specificity check. Study type: animal.
